297 related articles for article (PubMed ID: 23542636)
1. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Advanced HIV Disease, Cryptococcal Antigenemia, and Suboptimal Clinical Outcomes Among Those Enrolled in Care in Vietnam.
Dat VQ; Lyss S; Dung NTH; Hung LM; Pals SL; Anh HTV; Kinh NV; Bateganya M
J Acquir Immune Defic Syndr; 2021 Dec; 88(5):487-496. PubMed ID: 34446679
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand.
Harris JR; Lindsley MD; Henchaichon S; Poonwan N; Naorat S; Prapasiri P; Chantra S; Ruamcharoen F; Chang LS; Chittaganpitch M; Mehta N; Peruski L; Maloney SA; Park BJ; Baggett HC
Clin Infect Dis; 2012 Mar; 54(5):e43-50. PubMed ID: 22198791
[TBL] [Abstract][Full Text] [Related]
4. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcal antigenemia prevalence and clinical data in HIV-infected patients from the reference centre at INI-FIOCRUZ, Rio de Janeiro, Southeast of Brazil.
Ferreira MF; Brito-Santos F; Trilles L; Almeida MA; Wanke B; Veloso VG; Nunes EP; Lazera MDS
Mycoses; 2020 Feb; 63(2):145-150. PubMed ID: 31715053
[TBL] [Abstract][Full Text] [Related]
6. Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda.
Manabe YC; Nonyane BA; Nakiyingi L; Mbabazi O; Lubega G; Shah M; Moulton LH; Joloba M; Ellner J; Dorman SE
PLoS One; 2014; 9(7):e101459. PubMed ID: 25000489
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcal antigenemia and associated risk factors among ART-naïve and ART-experienced HIV-infected peoples at selected health institutions of Mekelle, Northern Ethiopia.
Hailu K; Niguse S; Hagos K; Abdulkader M
Microbiologyopen; 2019 Jun; 8(6):e00746. PubMed ID: 30277315
[TBL] [Abstract][Full Text] [Related]
8. Magnitude of Cryptococcal Antigenemia among HIV Infected Patients at a Referral Hospital, Northwest Ethiopia.
Derbie A; Ayalew W; Mekonnen D; Alemu M; Mulugeta Y
Ethiop J Health Sci; 2018 Jul; 28(4):369-374. PubMed ID: 30607049
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis.
Ssebambulidde K; Bangdiwala AS; Kwizera R; Kandole TK; Tugume L; Kiggundu R; Mpoza E; Nuwagira E; Williams DA; Lofgren SM; Abassi M; Musubire AK; Cresswell FV; Rhein J; Muzoora C; Hullsiek KH; Boulware DR; Meya DB;
Clin Infect Dis; 2019 May; 68(12):2094-2098. PubMed ID: 30256903
[TBL] [Abstract][Full Text] [Related]
11. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.
Meya DB; Manabe YC; Castelnuovo B; Cook BA; Elbireer AM; Kambugu A; Kamya MR; Bohjanen PR; Boulware DR
Clin Infect Dis; 2010 Aug; 51(4):448-55. PubMed ID: 20597693
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence and factors associated with cryptococcal antigenemia in HIV-infected patients in Cotonou/Benin].
Ogouyèmi-Hounto A; Zannou DM; Ayihounton G; Ahouada C; Azon-Kouanou A; Acakpo J; Sissinto Savi de Tove Y; Kinde Gazard D
J Mycol Med; 2016 Dec; 26(4):391-397. PubMed ID: 27641486
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Cryptococcal Antigen Screening of HIV-Infected Patients in Iran.
Bandalizadeh Z; Shokohi T; Moosazadeh M; Keikha N; Seyedpor H; Rabie Rudsari M; Babamahmoudi F; Ghasemian R; Mardani M; Javanian M; Soleimanpour S; Sefidgar AA; Shokri M; Gouya MM; Seyedmousavi S
Curr Microbiol; 2020 Aug; 77(8):1667-1672. PubMed ID: 32296917
[TBL] [Abstract][Full Text] [Related]
17. Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.
Pac L; Horwitz MM; Namutebi AM; Auerbach BJ; Semeere A; Namulema T; Schwarz M; Bbosa R; Muruta A; Meya DB; Manabe YC
J Acquir Immune Defic Syndr; 2015 Apr; 68(5):e69-76. PubMed ID: 25761234
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
19. Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker
Karaman E; Ilkit M; Kuşçu F
Mycoses; 2019 Oct; 62(10):961-968. PubMed ID: 31344286
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study.
Oyella J; Meya D; Bajunirwe F; Kamya MR
J Int AIDS Soc; 2012 Mar; 15(1):15. PubMed ID: 22417404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
